For the Inventor, By the Inventor

Enter assignee name

China Pharmaceutical University

Calculating rank

USPTO Granted Patents = 37

% Expired Patents = 18.9

CIPO Patents = 1

EPO Patents = 10

Forward Citations = 23

Loading Chart...

Loading Chart...

186 inventors (with patents filed for the assignee):

Qidong You (10 out of 12 patents)

Xiaoke Guo (6 out of 8 patents)

Zhengyu Jiang (5 out of 5 patents)

4. Xiaoli Xu (5 out of 7 patents)

5. Mengchen Lu (4 out of 4 patents)

6. Wenlong Huang (3 out of 3 patents)

7. Can Zhang (2 out of 2 patents)

8. Lei Zhang (2 out of 15 patents)

9. Sheng Jiang (2 out of 3 patents)

10. Haiping Hao (2 out of 3 patents)

11. Haopeng Sun (2 out of 3 patents)

12. Hua Xiang (2 out of 2 patents)

13. Hong Xiao (2 out of 2 patents)

14. Yao Yao (2 out of 3 patents)

15. Xiaobo Li (2 out of 2 patents)

Core Competencies:

Cinnamoyl Amino Acid

Indole Alkaloid

SHP2 Inhibitor

Butyrylcholinesterase Inhibitor

Oxyntomodulin Hybrid Peptide

Neutrophil Granulocyte Delivery

Bifunctional Fusion Proteins

Inflammation-targeted Delivery

Isoflavone Derivatives

Diterpene Lactones

Naphthalenesulfonamide

TRPV3 Application

37 patents: Sort by Forward Citations

1. 12723018 - Cinnamoyl amino acid compound and use thereof (2026-09-01),

2. 12606538 - Benzo[b]selenophene sting regulator, preparation method and use thereof (2026-04-21),

3. 12600724 - Indole alkaloid and preparation method and use thereof (2026-04-14),

4. 12492212 - Substituted pyrazolecarboxamides as sting activators (2025-12-09),

5. 12453731 - Aniline-based WDR5 protein-protein interaction inhibitor, and preparation method and use thereof (2025-10-28),

6. 12383535 - Hydrogen peroxide-responsive KEAP1-NRF2 ppi inhibitor prodrug, and preparation method therefor (2025-08-12),

7. 12331058 - SHP2 and CDK4/6 dual-target inhibitory compound and pharmaceutical composition containing the same (2025-06-17),

8. 12310944 - Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof (2025-05-27),

9. 12226476 - Helper epitope peptide and application thereof (2025-02-18),

10. 12144881 - Cosmetic composition containing α-mangostin, method for preparation, and uses thereof (2024-11-19),

11. 11970523 - Long-acting oxyntomodulin hybrid peptide, preparation method therefor, and application thereof (2024-04-30),

12. 11905230 - Phenoxyacetic acid derivatives, preparation method thereof and use thereof as medicament (2024-02-20),

13. 11773057 - Naphthalenesulfonamide compound, preparation method, and application (2023-10-03),

14. 11572359 - PARP/PI3K double-target inhibit containing pyridopyrimidine structure (2023-02-07),

15. 11541032 - Composition containing sumo inhibitor and application (2023-01-03),

Company Overview

China Pharmaceutical University, located in Nanjing, specializes in pharmaceutical sciences and healthcare education. The institution is renowned for its research in drug development, pharmacology, and pharmaceutical engineering, contributing significantly to advancements in the life sciences sector. With a strong emphasis on innovation, the university collaborates with various industries and research institutions, fostering a rich environment for academic and practical exploration in pharmaceuticals and related fields.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

37 Patents

#17 in Nanjing

#860 in China

#18,312 in the World

China Pharmaceutical University

Forward Citations = 23

186 inventors:

Qidong You (10 out of 12 patents)

Xiaoke Guo (6 out of 8 patents)

Zhengyu Jiang (5 out of 5 patents)

4. Xiaoli Xu (5 out of 7 patents)

5. Mengchen Lu (4 out of 4 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: China Pharmaceutical University. Retrieved from https://idiyas.com/company/china-pharmaceutical-university

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…